SUNNYVALE, Calif.--(BUSINESS WIRE)--Amarantus BioSciences, Inc. (OTCBB:AMBS), a biotechnology company developing MANF, a first-in-class disease–modifying therapeutic protein, today announced that both Gerald and Dr. John Commissiong are among the Bay Area selectees for the 12th Annual 50 Most Important African-Americans in Technology. The selectees will gather in Washington, D.C. January 14-15, 2012 for the 12th Annual Innovation and Equity Symposium themed: “Capitalizing Creativity: Innovation and Job Creation.” At the Innovation and Equity Symposium, participants will discuss a variety of relevant topics relating to African-Americans including the new America Invents Act and the low participation of African-American students in math and science courses.
